Prediction: This Will Be Palantir Technologies’ Stock Price by the End of 2028

Palantir reported Q2 revenue growth of 93% year over year to $1.94B and non-GAAP EPS growth of 156% to $0.41, while guiding for 2026 revenue of more than $8.15B, up 82%. U.S. commercial TCV rose 2.5x to $2.13B, total RDV increased 83% to $13.1B, and the company added 200 customers year over year, supporting a bullish view of its AI-software growth runway. The article argues that, if EPS doubles from the $1.61 2026 consensus estimate to $6.44 by 2028 and trades at 50x earnings, shares could reach $322, or 74% above current levels; the 12-month median analyst target is $210, implying 13% upside.

Analysis

The central investable issue is not demand visibility but conversion economics: PLTR must turn pilots and contractual value into recognized revenue while preserving its unusually high incremental margins. A growing installed base can support expansion bookings, but it also raises implementation capacity and customer-concentration risks; the relevant KPI is net dollar retention and time from initial deployment to eight-figure annualized spend, not headline contract value. Strong commercial execution would pressure adjacent data/AI-platform vendors such as SNOW, C3.ai (AI), and even MSFT’s lower-end Azure AI workload capture, though PLTR’s government/security positioning remains less substitutable.

The bullish valuation case embeds aggressive assumptions twice: sustained hypergrowth through a larger revenue base and a premium multiple despite normalization. The cited 2028 EPS framework contains a compounding error—doubling $1.61 once produces $3.22, not $6.44—so the implied upside is materially overstated before accounting for stock-based-compensation dilution. At a rich forward earnings multiple, even an earnings beat can fail to move the stock unless management raises forward revenue and margin targets; the next 1-3 months are therefore a guidance-quality trade, while the 6-18 month risk is that enterprise AI budgets consolidate around hyperscalers or internally built tools.

Consensus may be underestimating operating leverage if commercial customers standardize on PLTR after successful deployments, but is also likely treating remaining deal value as equivalent to backlog. Contracts can contain options, multi-year delivery obligations, and uneven revenue recognition; investors should demand evidence that RDV is converting faster than revenue growth and that deferred revenue/cash collections corroborate it. The thesis is falsified by a sequential slowdown in U.S. commercial bookings, declining net retention, materially rising SBC/share count, or guidance that implies deceleration before the installed base monetizes.

Key Decisions for Investors

• Do not chase the recent momentum. Initiate or add to PLTR only after the next results demonstrate raised full-year revenue guidance and stable/improving adjusted operating margin; target a 6-12 month position with a 15-20% risk limit, as multiple compression can dominate a modest beat.
• For event exposure, use a defined-risk PLTR call spread 6-9 months out rather than outright shares: buy an at/near-the-money call and sell a 20-30% out-of-the-money call. This expresses upside from another guidance reset while limiting exposure to a post-earnings valuation de-rate.
• Pair a tactical long PLTR against short AI from initiation only if PLTR commercial bookings and retention accelerate while AI fails to show comparable enterprise conversion. Reassess within 1-2 quarters; the pair is invalid if AI’s growth reaccelerates or PLTR’s commercial revenue growth decelerates materially.
• Set a diligence alert around cash conversion: avoid adding if billings/deferred revenue lag reported revenue for two consecutive quarters or diluted share growth exceeds management’s implied earnings-growth advantage. These would indicate that the apparent operating leverage is lower quality than adjusted EPS suggests.